Table 1.
n5 | Day 2 | Day 9 | Day 16 | Day 23 | Day 32 | Day 39 | Day 46 | Day 55 | Day 60 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Control group1 | AM3 | 10 | 15.7 | 19.5 | 21.9 | 18.5 | 19.2 | 15.7 | 17.9 | 16.9 | 14.2 |
Treated group2 | AM3 | 10 | 1.6 | 0.0 | 0.0 | 0.0 | 0.2 | 0.5 | 0.7 | 2.0 | 5.3 |
% Efficacy4 | 89.8 | 100.0 | 100.0 | 100.0 | 99.0 | 96.8 | 96.1 | 88.2 | 62.7 | ||
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0191 |
The Control (CP) group was treated topically once on Day 0 with 0.12 mL/kg Technical oil.
The Treated (IVP) group was treated topically once on Day 0 with 0.12 mL/kg of the novel formulation of (S)afoxolaner, eprinomectin and praziquantel.
Percent efficacy = [(C − T)/C] × 100, where T and C are arithmetic means (AM) of the IVP group and the CP group, respectively.
p-value = two-sided p-value from the MIXED model of the IVP group and the CP group.
n = number of cats per group: one cat was removed on Day 50 because deemed unsuitable to remain in the study for excessive tick bite wounds, consequently n = 9 in the control group on Days 55 and 60.